Saudi Arabia Precision Medicine Market: Size, Demand, Growth & Outlook by 2033

Saudi Arabia Precision Medicine Market Overview

Market Size in 2024: USD 762.0 Million

Market Size in 2033: USD 1,593.6 Million

Market Growth Rate 2025-2033: 8.54%

According to IMARC Group's latest research publication, "Saudi Arabia Precision Medicine Market Report by Product (Consumables, Instruments, Services), Technology (Big Data Analytics, Bioinformatics, Gene Sequencing, Drug Discovery, Companion Diagnostics, and Others), Application (Oncology, Central Nervous System (CNS), Immunology, Respiratory Medicine, Infections, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Pharma and Biotech Companies, Healthcare IT Firms, and Others), and Region 2025-2033", The Saudi Arabia precision medicine market size reached USD 762.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,593.6 Million by 2033, exhibiting a growth rate (CAGR) of 8.54% during 2025-2033.

How AI is Reshaping the Future of Saudi Arabia Precision Medicine Market

• Saudi genetic and omics companies are tapping AI to analyze massive data sets, accelerating personalized treatment strategies for cancer and rare diseases across the Kingdom.
• The Saudi Human Genome Program uses AI-powered analytics, helping to map over 1 million genomes and unlocking new breakthroughs in targeted, precision medicine nationwide.
• Nearly 34% of Saudi precision medicine startups invest in AI-driven diagnostic platforms, which are cutting diagnosis times for complex diseases by half in top hospitals.
• The government’s Vision 2030 agenda channels over $500 million into AI and digital health R&D, fast-tracking innovations in customized healthcare delivery and drug discovery.
• Leading hospital groups now use AI imaging tools that boost accuracy up to 95%, supporting remote monitoring and expanding access to personalized care in rural regions.

Download a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-precision-medicine-market/requestsample

Saudi Arabia Precision Medicine Market Trends & Drivers:

A big driver of precision medicine in Saudi Arabia is the large-scale investment in healthcare digitization and bioinformatics under the Vision 2030 agenda. The government has earmarked over $500 million for national digital health transformation, supporting advanced data platforms and research on genetic disorders. The Saudi Human Genome Program is a standout, having already mapped more than 1 million genomes with AI-enabled technology, enabling highly targeted therapies for cancer and rare diseases. This push is rapidly moving personalized care from a buzzword into real-world clinical practice, setting a regional benchmark for tech-led health initiatives and attracting global biotech collaborations.

The growing adoption of artificial intelligence and machine learning in Saudi hospitals and labs is transforming the precision medicine field, making it faster and more accessible for a broader population. Leading providers are deploying AI diagnostic platforms that can analyze multi-omics data and imaging scans with over 95% accuracy. These tools are significantly reducing diagnostic times, particularly for complex or rare conditions. Saudi start-ups and hospital groups are also investing in AI-powered decision support, enabling clinicians to deliver customized treatments and monitor chronic diseases remotely—an advance that helps reach even rural communities outside Jeddah and Riyadh.

The expanding role of local and global biotech companies is another key factor reshaping the Saudi precision medicine landscape. Several homegrown start-ups and leading international players are building partnerships to pilot genetic testing solutions in Saudi clinics, focusing on inherited diseases and cancer predispositions. Real-world collaborations, such as partnerships between the Ministry of Health and Saudi Data & AI Authority, have resulted in nationwide platforms for digital health and personalized therapeutics. The rapid uptake of these innovations is reflected in industry reports showing around 34% of healthtech companies in the Kingdom now specializing in AI-driven precision medicine applications, demonstrating how this sector is scaling up and driving impactful change.

Ask analyst of customized report: https://www.imarcgroup.com/request?type=report&id=20858&flag=E

Saudi Arabia Precision Medicine Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

• Consumables
• Instruments
• Services

Technology Insights:

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Drug Discovery
• Companion Diagnostics
• Others

Application Insights:

• Oncology
• Central Nervous System (CNS)
• Immunology
• Respiratory Medicine
• Infections
• Others

End User Insights:

• Hospitals and Clinics
• Diagnostic Centers
• Pharma and Biotech Companies
• Healthcare IT Firms
• Others

Regional Insights:

• Northern and Central Region
• Western Region
• Eastern Region
• Southern Region

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Recent News and Developments in Saudi Arabia Precision Medicine Market

• September 2025: Saudi Human Genome Program surpasses 1 million sequenced genomes, enabling AI-driven diagnostics for rare and hereditary diseases across major hospitals.
• September 2025: Over 34% of Saudi healthtech start-ups now offer AI-powered multi-omics platforms, accelerating personalized cancer care and targeted treatment discovery.
• September 2025: Ministry of Health and SDAIA launch a national platform integrating big data and machine learning to enhance early disease prediction and precision therapeutics.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302